Search
for
Sort by
Research 241–270 of 1000+
- Janus Kinase inhibitors in dermatology: a review
- British Hair and Nail Society
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Ottawa, Ontario, Canada, February 13–16, 2013
- Dermatologic Adverse Events from Cancer Treatments
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Micro-Needling Depth Penetration, Presence of Pigment Particles, and Fluorescein-Stained Platelets: Clinical Usage for Aesthetic Concerns
- Skin health of community-living older people: a scoping review
- Evidence for the off-label use of tofacitinib in alopecia areata
- Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin
- Efficacy and safety of mycophenolate mofetil for lichen planopilaris
- Primary cicatricial alopecia
- Erosive pustular dermatosis of the scalp: Clinical, trichoscopic, and histopathologic features of 20 cases
- TOXIC EPIDERMAL NECROLYSIS
- Involvement of scalp and nails in lupus erythematosus
- Update on the dermatologic use of systemic glucocorticosteroids
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
- Profile of dermatological consultations in Brazil (2018)
- The Basic Science of Hair Biology
- Finasteride Treatment of Hair Loss in Women
- Scalp Itch: A Systematic Review
- New drugs under investigation for the treatment of alopecias
- <i>Platycladus orientalis</i> Leaves: A Systemic Review on Botany, Phytochemistry and Pharmacology
- Teriflunomide in multiple sclerosis: an update
- ADVANCES IN PSORIASIS THERAPY
- Skin manifestations of chronic kidney disease
- Hair and nail involvement in lupus erythematosus
- Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study